#genetic-data
#genetic-data

Marketing tech

23andMe Cofounder Anne Wojcicki Wins Bid, Takes Back Company | Entrepreneur

fromTechCrunch

EU data protection

23andMe says 15% of customers asked to delete their genetic data since bankruptcy | TechCrunch

fromwww.bbc.com

Struggling DNA testing firm 23andMe to be bought for $256m

23andMe is being acquired by Regeneron Pharmaceuticals for $256 million post-bankruptcy, ensuring continued privacy protections for users.

fromSFGATE

NYC startup

23andMe threatens 223 layoffs, including execs, as bankruptcy deadline nears

3 months ago

Bankrupt 23andMe faces scrutiny by U.S. House Committee as government seeks testimony from cofounder

23andMe's bankruptcy raises concerns over genetic data security and potential misuse.

OMG science

fromFuturism

23andMe Is Selling All Your Data, in Largest Sale of Genomes in History

23andMe's DNA data from 15 million individuals is being auctioned, raising concerns about privacy versus potential scientific benefits.

fromEntrepreneur

Marketing tech

23andMe Cofounder Anne Wojcicki Wins Bid, Takes Back Company | Entrepreneur

fromTechCrunch

EU data protection

23andMe says 15% of customers asked to delete their genetic data since bankruptcy | TechCrunch

fromwww.bbc.com

Struggling DNA testing firm 23andMe to be bought for $256m

23andMe is being acquired by Regeneron Pharmaceuticals for $256 million post-bankruptcy, ensuring continued privacy protections for users.

fromSFGATE

NYC startup

23andMe threatens 223 layoffs, including execs, as bankruptcy deadline nears

3 months ago

Privacy professionals

Bankrupt 23andMe faces scrutiny by U.S. House Committee as government seeks testimony from cofounder

OMG science

fromFuturism

23andMe Is Selling All Your Data, in Largest Sale of Genomes in History

23andMe's DNA data from 15 million individuals is being auctioned, raising concerns about privacy versus potential scientific benefits.

more#23andme

fromArs Technica

Biotech company Regeneron to buy bankrupt 23andMe for $256M

As a world leader in human genetics, Regeneron Genetics Center is committed to and has a proven track record of safeguarding the genetic data of people across the globe, and, with their consent, using this data to pursue discoveries that benefit science and society.

Privacy professionals

#regeneron

fromThe Mercury News

Marketing tech

Biotech company Regeneron buying 23andMe for $256 million

Marketing tech

23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals

Regeneron Pharmaceuticals has acquired 23andMe for $256 million, committing to uphold privacy standards for sensitive genetic data.

fromThe Mercury News

Marketing tech

Biotech company Regeneron buying 23andMe for $256 million

Marketing tech

23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals

Regeneron Pharmaceuticals has acquired 23andMe for $256 million, committing to uphold privacy standards for sensitive genetic data.

What Happens When Hackers Get Your DNA Data? Ask 23andMe | HackerNoon

The 23andMe breach highlights the vulnerabilities of genomic data and the urgent need for enhanced security and regulatory measures.

#privacy

fromTheregister

Genetic data sharing service openSNP to close down

OpenSNP will shut down due to risks of genetic data misuse, especially following 23andMe's bankruptcy.

EU data protection

fromABC7 San Francisco

AG Bonta reminds 23andMe customers of the right to delete their data

Customers can request deletion of their genetic data from 23andMe to protect their privacy amid financial worries about the company.

fromTheregister

Genetic data sharing service openSNP to close down

OpenSNP will shut down due to risks of genetic data misuse, especially following 23andMe's bankruptcy.

EU data protection

fromABC7 San Francisco

AG Bonta reminds 23andMe customers of the right to delete their data

Customers can request deletion of their genetic data from 23andMe to protect their privacy amid financial worries about the company.

more#privacy

fromwww.theguardian.com